Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (2X), two next-generation ...

Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).

Thermo Fisher Scientific (TMO) just picked up fresh buy ratings on the back of its Asian bioprocessing expansion and a new ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 13 Best Nanotechnology Stocks to Buy Now. According to The Fly, on ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $390.0 to $560.0 for Thermo Fisher Scientific over the recent three months.

Fintel reports that on December 9, 2025, Goldman Sachs initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation. Analyst Price Forecast Suggests 11.10% Upside As of December ...

To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...

Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 10 years by 2.35% on an annualized basis producing an average annual return of 15.14%. Currently, Thermo Fisher ...

Goldman Sachs names Agilent, Danaher, and Thermo Fisher Scientific as top life sciences stock picks. Read more here.

According to MarketsandMarkets™, the US In Vitro Diagnostics Market is projected to grow from about USD 37.43 Billion in 2025 ...

The global microplate systems market is projected to grow at a compound annual growth rate (CAGR) of approximately 4% over ...